Mesenchymal stromal cell derivatives
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesenchymal stromal cell derivatives, covering 2016-10-24 to 2016-10-24. Get the full timeline:
Most recent: Clinical Trial Update: Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2 [Phase 1, Phase 2]